Back
Rhythm Pharmaceuticals Stock Price Chart
Sponsored
RYTM
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
RYTM
Rhythm Pharmaceuticals
Last Price:
$55.81
Seasonality Move:
-14.94%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.
Rhythm Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.56 | Buy |
20-day SMA: | 57.84 | Sell |
50-day SMA: | 56.36 | Sell |
200-day SMA: | 47.04 | Buy |
8-day EMA: | 55.99 | Sell |
20-day EMA: | 56.89 | Sell |
50-day EMA: | 56 | Sell |
200-day EMA: | 48.31 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 46.14 | Sell |
Chaikin Money Flow: | 10036 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.82 - 60.58) | Sell |
Bollinger Bands (100): | (46.59 - 58.07) | Buy |
Rhythm Pharmaceuticals Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 55.85 while RYTM 8-day simple moving average is 55.56, which is a Buy signal.
-
The stock price of RYTM is 55.85 while Rhythm Pharmaceuticals 20-day SMA is 57.84, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day simple moving average is 56.36 while RYTM share price is 55.85, making it a Sell technically.
-
RYTM stock price is 55.85 and Rhythm Pharmaceuticals 200-day simple moving average is 47.04, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Sell
46
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a SellThe current Rhythm Pharmaceuticals [RYTM] share price is $55.85. The Score for RYTM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.4B
Price in USD:
55.85
Share Volume:
194.7K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
68.58
52-Week Low:
35.17
Sell
46
Rhythm Pharmaceuticals (RYTM)
is a Sell
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 55.85 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 55.85 while RYTM 8-day exponential moving average is 55.99, which is a Sell signal.
-
The stock price of RYTM is 55.85 while Rhythm Pharmaceuticals 20-day EMA is 56.89, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 56.00 while RYTM share price is 55.85, making it a Sell technically.
-
RYTM stock price is 55.85 and Rhythm Pharmaceuticals 200-day simple moving average is 48.31, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.77 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is -0.6, suggesting Rhythm Pharmaceuticals is a Sell
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 46.14, which suggest Rhythm Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (55.82 - 60.58), which suggest Rhythm Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (46.59 - 58.07), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.